Hepatitis B virus causes both acute (transient) and chronic infections. The latter, in particular, create a very high risk of primary hepatocellular carcinoma (PHC). Significant effort has consequently been devoted to understanding chronic infections, since it is believed that if a chronic infection could be cured, especially prior to extensive and prolonged liver damage, the risk of PHC would bc greatly reduced. It has, by now, become clear that our lack of understanding of how hepadnaviruses maintain chronic infections, in vivo, has limited our ability to design widely-applicable anti-hepadnavirus therapies as well as to understand the progression from infection to liver cancer. The widespread belief that hepatocytes are largely nondividing and, therefore, virtually immortal, at least in the absence of toxic or immune injury has, indeed, been a major conceptual barrier in understanding the critical issue of how subclinical infections are naturally resolved, since hepadnaviruses appear highly adapted to productively infect stationary cells and in vivo infections are traditionally viewed to be noncytopathic. The longterm objective of our research is, therefore, to learn more about cell turnover in the normal liver and how it may change in response to a hepadnavirus infection. Through the proposed studies, we expect to achieve the following goals. 1) To determine whether infection of hepatocytes significantly reduces the life-span of the infected cells, even in the absence of an antiviral immune response. 2) To determine if hepatocytes are replaced by proliferation or a specialized pool of progenitors within the liver and whether such progenitors are susceptible to hepadnavirus infection. 3) To determine if the cellular immune response to infected hepatocytes causes a rapid repopulation of the liver with """"""""altered"""""""" hepatocytes. These experiments will be carried out with Pekin ducks chronically and transiently infected with duck hepatitis B virus and with woodchucks infected with woodchuck hepatitis virus. The results will provide an understanding of how hepadnaviruses maintain chronic in vivo infections together with a description of early changes in the hepadnavirus-infected liver leading to hepatocellular carcinoma.
| Yamamoto, Toshiki; Litwin, Samuel; Zhou, Tianlun et al. (2002) Mutations of the woodchuck hepatitis virus polymerase gene that confer resistance to lamivudine and 2'-fluoro-5-methyl-beta-L-arabinofuranosyluracil. J Virol 76:1213-23 |
| Zhu, Y; Yamamoto, T; Cullen, J et al. (2001) Kinetics of hepadnavirus loss from the liver during inhibition of viral DNA synthesis. J Virol 75:311-22 |
| Zhou, T; Saputelli, J; Aldrich, C E et al. (1999) Emergence of drug-resistant populations of woodchuck hepatitis virus in woodchucks treated with the antiviral nucleoside lamivudine. Antimicrob Agents Chemother 43:1947-54 |
| Dube, D K; Dube, S; Erensoy, S et al. (1994) Serological and nucleic acid analyses for HIV and HTLV infection on archival human plasma samples from Zaire. Virology 202:379-89 |
